TriNetX通过收购Zetta Genomics的关键资产，增强了其在全球供应商网络中联合基因组数据的能力-动脉网

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

PR Newswire 等信源发布 2026-04-07 19:32



可切换为仅中文







TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation

TriNetX® 将继续支持所有使用获奖的 XetaBase® 技术进行研究和患者护理创新的现有 Zetta Genomics 客户。

CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom

马萨诸塞州剑桥和英国剑桥

，

April 7, 2026

2026年4月7日

/PRNewswire/ -- TriNetX, the world's leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and current TriNetX partner. The acquisition expands TriNetX's genomics data management and analytics capabilities, supporting federated capture of multiomic data.

/PRNewswire/ -- 全球领先的联邦健康数据网络 TriNetX 今天宣布，已收购总部位于英国剑桥的医疗技术公司 Zetta Genomics 的关键资产，该公司也是 TriNetX 的现有合作伙伴。此次收购扩展了 TriNetX 在基因组数据管理与分析方面的能力，支持多组学数据的联邦捕获。

This accelerates healthcare providers' ability to integrate phenotypic and multiomic data for improved care delivery and clinical research and enhances the ability of TriNetX's life science customers to perform large-data research in a cost-effective manner. .

这加速了医疗保健提供者整合表型和多组学数据以改进护理服务和临床研究的能力，并增强了TriNetX的生命科学客户以具有成本效益的方式进行大数据研究的能力。

Zetta's flagship platform, XetaBase, is a multiomic capture and analytics platform designed for population‑scale genomic analysis. XetaBase is currently in use by leading healthcare provider organizations, life sciences companies, and research institutes.

Zetta的旗舰平台XetaBase是一个多组学捕获与分析平台，专为群体规模的基因组分析而设计。XetaBase目前正被领先的医疗保健机构、生命科学公司和研究机构使用。

TriNetX and Zetta have worked closely together since 2024 as part of TriNetX's genomics data program. During this collaboration, the companies completed substantial technical feasibility work demonstrating secure, federated querying across genomic and phenotypic data to deliver high-integrity, analytically robust insights.

自2024年以来，TriNetX和Zetta作为TriNetX基因组数据计划的一部分密切合作。在此合作期间，这些公司完成了大量的技术可行性工作，展示了在基因组和表型数据之间进行安全的联合查询，以提供高完整性和分析稳健的洞察。

This work establishes a strong foundation for further expansion..

这项工作为进一步的扩展奠定了坚实的基础。

'Through our partnership activities, led by our Chief Operating Officer Steve Kundrot and team, we have developed deep familiarity with Zetta's leadership, technological prowess, and fit-for-purpose approach and have been consistently impressed with Zetta's trusted healthcare provider relationships and robust analytics platform,' said Jeff Margolis, Executive Chairman of TriNetX.

“通过我们的合作伙伴活动，在首席运营官史蒂夫·昆德罗特及其团队的领导下，我们对Zetta的领导力、技术实力和目标导向方法有了深入的了解，并且始终对Zetta值得信赖的医疗提供商关系和强大的分析平台印象深刻，”TriNetX执行主席杰夫·马戈利斯表示。

'Welcoming Zetta's XetaBase platform into the TriNetX ecosystem represents an important milestone for our organization.'.

“欢迎Zetta的XetaBase平台加入TriNetX生态系统，这对我们的组织来说是一个重要的里程碑。”

Mr. Margolis continued, 'This acquisition reflects our commitment to advancing multiomic-enabled research and supporting healthcare providers with a practical, localized approach to scaling their data infrastructures.'

马戈利斯继续说道：“此次收购反映了我们致力于推进多组学研究，并通过实用的、本地化的方法支持医疗保健提供商扩展其数据基础设施。”

Jeffrey Brown, PhD, TriNetX Chief Scientific Officer added, 'Our purpose of driving better human health through data is clearly enhanced by adding the XetaBase technology, as we strongly believe the integration of different data types is essential to clinical and scientific progress.'

杰弗里·布朗博士，TriNetX首席科学官补充道：“我们通过数据推动人类健康的目标显然会因添加XetaBase技术而得到加强，因为我们坚信不同类型数据的整合对于临床和科学的进步至关重要。”

'I am proud of what the Zetta team has built and excited to see XetaBase become part of the TriNetX array of data, software, and intelligence capabilities,' said Ignacio Medina Castello, Chief Executive Officer and Chief Technology Officer of Zetta Genomics. 'From the beginning, our collaboration with TriNetX demonstrated that genomic and clinical data can be securely connected in a federated way at scale.

“我为Zetta团队所建立的成果感到自豪，并且很高兴看到XetaBase成为TriNetX数据、软件和智能能力阵容的一部分，”Zetta Genomics首席执行官兼首席技术官伊格纳西奥·梅迪纳·卡斯特略表示。“从一开始，我们与TriNetX的合作就表明，基因组和临床数据能够以联合的方式在大规模范围内安全连接。”

Fully joining forces with TriNetX allows that work to move forward faster and to reach a broader global community of healthcare and research partners.'.

全面与TriNetX合作可以使这项工作更快地推进，并触及到更广泛的全球医疗和研究合作伙伴。

About TriNetX, LLC

关于TriNetX有限责任公司

TriNetX is The Global Truth Engine for Better Human Health™, helping organizations understand what's really happening in patient care. We connect health systems, researchers, and companies around the globe to real‑world patient data so they can make better‑informed decisions—based on reality, not assumptions..

TriNetX 是改善人类健康的全球真实引擎™，帮助组织了解患者护理中真正发生的情况。我们连接全球的卫生系统、研究人员和公司，获取真实世界中的患者数据，以便他们能够基于现实而非假设做出更为明智的决策。

Data is sourced directly from 11,000+ healthcare provider sites across more than 20 countries and kept within those institutions to protect accuracy, privacy, and trust. TriNetX combines this data with scientific expertise and technology to help customers ask better questions, interpret results, and move forward with confidence..

数据直接来源于横跨 20 多个国家/地区的 11,000 多个医疗保健提供方站点，并保存在这些机构内部，以保护准确性、隐私和信任。TriNetX 将此数据与科学专业知识和技术相结合，帮助客户提出更好的问题、解读结果并满怀信心地向前迈进。

Learn more at

了解更多内容，请访问

trinetx.com

TriNetX.com

or follow TriNetX on

或关注TriNetX

领英

。

Media Contact

媒体联系人

TriNetX